(Date:12/2/2009)... , QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ -...(the "Company"), a global biopharmaceutical compan... announced that the U.S. Food and Drug Administrat...he Company,s PI3K/Akt pathway inhibitor compound, ...ed/refractory multiple myeloma. Keryx Biopharmaceu...
(Date:12/1/2009)..., INCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-Fir...I ) today announced revenue guidance for the fourt... $57 million, as compared with $69 million for the...r 2008 results was the first of two installment pa...ed in fourth quarter 2008 results was a one-time $...
(Date:12/1/2009)... , CAMBRIDGE, Mass., Dec. 1 /PRNewswire/...ogy industry and to promote its potential, a group...ion of the Synthetic Biology Industry Association ...e goal of the association is to provide a forum fo...the new industry, address its opportunities and it...
(Date:12/1/2009)... , SAN FRANCISCO, Dec. 1 The Bu...most half the value it lost in October. The Select...xcellent month for the general markets with the Do...value. The gains held firm in the final two tradin... sluggish Thanksgiving holiday shopping and Dubai,...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4...EAPOLIS, May 19 G. Arthur Herbert, a Techne Corpo...s Audit Committee, Executive Compensation Committe...ed today that he is planning to retire at the end ... shareholders reelect Directors on an annual basis...r re-nomination as a Director for fiscal year 2010...
... ALTO, Calif., May 19 Pioneering medical device c...learance from the U.S. Food and Drug Administratio...ice, the ,Signos,. , , (Photo: http://www.newsco...ics has developed a cost-effective device that for... health professionals to use ultrasound in their c...
...t-in-class Oral Therapeutic for IBD with Novel Mod...ChemoCentryx, Inc., today announced that data from...ed Oral Therapy Evaluation in Crohn,s disease Tria...(CCX282-B) in patients with moderate-to-severe Cro...at the upcoming 2009 Digestive Disease Week (DDW) ...
Other Biology Technology:Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors 2Signostics Receives FDA Clearance for World's Smallest Ultrasound Product 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 3ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 4ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 5(Date:12/1/2009)... Particularly in Alzheimer,s disease, nerve cell d...ew therapeutic options may possibly be derived fro...sm. These findings have been published in the curr...ence . Until only a few years ago, neurogenesis t...ed to be impossible in the adult brain. The textbo...
(Date:12/1/2009)... Yehezkel Ben-Ari, winner of the 2009 Inserm Grand...ed its commitment to paying tribute to outstanding...ts. By honouring talents, Inserm intends to,demon...lved in today,s biological, medical and,health re...and women who carry out and,drive this research e...
(Date:12/1/2009)... In a world first, a Monash University-led interna...ay to boost the output of the next generation of s...n collaboration with colleagues from the universit...d tandem dye-sensitised solar cells with a three-f...red with previously reported tandem dye-sensitised...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Innovation puts next-generation solar cells on the horizon 2STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 1STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 2STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 3NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 1NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 2NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 3Gene Mutation Is Linked to Heart Muscle Disease 51799 1Gene Mutation Is Linked to Heart Muscle Disease 51799 2Mouse Anti-Human Spastin Monoclonal Antibody, Unconjugated, Clone Sp 3G11/1 from Santa Cruz Biotechnology, Inc.
mCD-1 Multi-Probe Template Set from BD Biosciences Pharmingen
Custom Immunization from Proteintech Group, Inc.
Rat Anti-Mouse VCAM-1 / CD106 Monoclonal Antibody, Unconjugated, Clone 112702 from R&D Systems
Biology Products: